← Browse by Condition
Medical Condition
ocular hypertension
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 4
NCT06689696
Recruiting
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
Enrollment
125 pts
Location
United States
Sponsor
Smartlens, Inc.
NCT07218796 Phase 3
Recruiting
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Enrollment
400 pts
Location
United States
Sponsor
SpyGlass Pharma, Inc.
NCT07325240 Phase 4
Recruiting
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic